Merck Serono
Also known as: Ayudas Merck Serono de Investigación 2012 | Beijing Merck Pharmaceutical Consulting Ltd., China | EMD Serono | EMD SERONO | EMD Serono a division of EMD Canada Inc. | EMD Serono Canada Inc. | EMD Serono, Inc. | EMD SERONO INC | EMD Serono Inc., a business of Merck KGaA, Darmstadt, Germany | EMD Serono Inc., an affiliate of Merck KGaA, Darmstadt, Germany | EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany | EMD Serono Inc., an Affiliate of Merck KGaA, Darmstadt, Germany | EMD Serono Inc., a subsidiary of Merck KGaA, Darmstadt, Germany | EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany | EMD Serono, Inc., Billerica MA, a subsidiary of Merck KGaA, Darmstadt, Germany | EMD Serono, Inc., Rockland MA, a subsidiary of Merck KGaA, Darmstadt, Germany | EMD Serono Research & Development Institute, Inc. | EMD Serono Research & Development Institute, Inc, a business of Merck KGaA, Darmstadt, Germany | EMD Serono Research & Development Institute, Inc. a business of Merck KGaA, Darmstadt, Germany | EMD Serono Research & Development Institute, Inc., a business of Merck KGaA, Darmstadt, Germany | EMD Serono Research & Development Institute, Inc, an affiliate of MerckKGaA, Darmstadt, Germany | EMD Serono Research & Development Institute, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany | EMD Serono Research & Development Institute, Inc., the biopharmaceutical division of Merck KGaA, Darmstadt, Germany | Merck Serono, a division of Merck KGaA, Darmstadt, Germany | Merck Serono Australia Pty Ltd | Merck Serono Austria a division of Merck Gesellschaft mbH, Austria, an affiliate of Merck KGaA, Darmstadt, Germany | Merck Serono Co.,Ltd, an Affilate of Merck Serono, Darmstadt, Germany | Merck Serono Co., Ltd., Beijing | Merck Serono. Co., Ltd, Beijing, China | Merck Serono Co., Ltd., China | Merck Serono Co., Ltd., Japan | Merck Serono Europe Limited, an affiliate of MerckKGaA, Darmstadt, Germany | Merck Serono Europe Ltd | Merck Serono GmbH, Germany | Merck Serono International SA | Merck Serono International S.A., an affiliate of Merck KGaA, Darmstadt, Germany | Merck Serono International SA, an affiliate of Merck KGaA Darmstadt, Germany | Merck Serono International, S.A., an affiliate of Merck KGaA, Darmstadt, Germany | Merck Serono Limited, UK | Merck Serono Middle East FZ LLC | Merck Serono Norway | MerckSerono Pharmaceuticals | Merck Serono SA | Merck Serono S.A., a business of Merck KGaA, Darmstadt, Germany | Merck Serono S.A., an affiliate of Merck KGaA, Darmstadt, Germany | Merck Serono SA, an affiliate of Merck KGaA, Darmstadt, Germany | Merck Serono S.A., Geneva | Merck Serono SA - Geneva | Merck Serono S.A. - Geneva, an affiliate of MerckKGaA, Darmstadt, Germany | Merck Serono SA - Geneva, an affiliate of Merck KGaA Darmstadt, Germany | Merck Serono S.A.S., an affiliate of Merck KGaA, Darmstadt, Germany | Merck Serono S.A.S, France | Merck Serono Spain | Merck Serono, Spain | Merck Serono S.P.A., Italy | Merck Serono Vietnam | Merck Services U.K. Ltd, UK
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2006First marketed drug
Jan 1, 2006First NDA
Feb 3, 2021Last known activity
Nov 15, 2025
Timeline
1970s
- Aug 22, 1975
luteinizing hormone— NDA Organization
2000s
- Aug 11, 2000
cetrorelix— NDA Secondary Org
- May 31, 2002
levothyroxine— Marketing Organization
- Jan 1, 2006
Merck Serono— Founded
- Jan 1, 2006
Merck KGaA— Acquired
2020s
- Dec 20, 2021
Chord Therapeutics— Acquired
- Apr 28, 2025
SpringWorks Therapeutics, Inc.— Acquired
Drugs by trial phase (242 distinct, 567 trials)
Phase 4 (4 own, 34 via acquisition)
Phase 3 (7 own, 40 via acquisition)
Phase 2 (17 own, 76 via acquisition)
Phase 1 (5 own, 55 via acquisition)
Other trials (1 own, 3 via acquisition)
Indications
Approved for
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Coronary Syndrome
- Adenocarcinoma
- Alzheimer Disease
- Amenorrhea
- Angina Pectoris
- Angina, Stable
- Anovulation
- Anus Neoplasms
- Arthritis
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Autoimmune Diseases
- Autoimmune Diseases of the Nervous System
- Biliary Tract Neoplasms
- Breast Neoplasms
- Cachexia
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Cholangiocarcinoma
- Cognitive Dysfunction
- Colitis
- Colitis, Ulcerative
- Colonic Neoplasms
- Colorectal Neoplasms
- Coronary Artery Disease
- Coronary Disease
- Coronavirus Infections
- Crohn Disease
- Demyelinating Autoimmune Diseases, CNS
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Dwarfism
- Dwarfism, Pituitary
- Dyskinesias
- Endocrine System Diseases
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Essential Hypertension
- Failure to Thrive
- Fetal Growth Retardation
- Fractures, Stress
- Gallbladder Neoplasms
- Glioblastoma
- Glomerulonephritis, IGA
- Gonadal Dysgenesis
- Head and Neck Neoplasms
- Heart Diseases
- Heart Failure
- Hematologic Neoplasms
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- HIV Infections
- HIV Wasting Syndrome
- Hyperprolactinemia
- Hypertension
- Hypogonadism
- Hypopituitarism
- Immunologic Deficiency Syndromes
- Infertility
- Insulin Resistance
- Kidney Diseases
- Kidney Neoplasms
- Leiomyosarcoma
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Limb Deformities, Congenital
- Lipodystrophy
- Liver Diseases
- Liver Neoplasms
- Lordosis
- Lung Diseases
- Lung Diseases, Interstitial
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Lupus Nephritis
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Melanoma
- Metabolic Syndrome
- Microsatellite Instability
- Multiple Myeloma
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Myelitis
- Myelitis, Transverse
- Myocardial Ischemia
Marketed drugs (16)
Subsidiaries (3 direct, 46 total across the full acquisition tree)
- Chord Therapeutics
- Merck KGaA
- SpringWorks Therapeutics, Inc.
- Amptec L2
- AZ Electronics L2
- Lexigen Pharmaceuticals L2
- Lipha L2
- Millipore L2
- ProteoPlex L2
- Qlight Nanotech L2
- Serono L2
- Sigma-Aldrich L2
- Advanced Separation Technologies L3
- Aldrich L3
- Amicon Separation Science L3
- Beijing Superior Chemicals and Instruments Co L3
- BioAnaLab L3
- Bioprocessing Limited L3
- BioReliance L3
- Degussa L3
- Epichem Group L3
- Genset L3
- Guava Technologies L3
- Interpharm L3
- Iropharm L3
- Isotec L3
- JRH Biosciences L3
- Microsafe Laboratories BV L3
- Molecular Medicine BioServices L3
- Newport Bio Systems L3
- Novaseptic AB L3
- Pharmorphix L3
- Serologicals Corporation L3
- Sigma Chemical Company L3
- Sorebio L3
- Tylan General L3
- Ultrafine L3
- Waters Associates L3
- Asta Medica L4
- Asta Werke L4
- Bioscot, Ltd. L4
- Chemisch-Pharmazeutische AG L4
- Muro Pharmaceuticals L4
- Proligo L4
- Sarget S.A. L4
- Pharmacy Barthe L5
Recent trials (50)
- NCT07094893CollaboratorPhase 4Nov 15, 2025
- NCT07166601OfficialPhase 1Oct 10, 2025
- NCT07166601Lead sponsorPhase 1Oct 10, 2025
- NCT07097259OfficialPhase 1Jul 21, 2025
- NCT07097259Lead sponsorPhase 1Jul 21, 2025
- NCT06869473CollaboratorPhase 2Feb 20, 2025
- NCT06710132Lead sponsorPhase 1/Phase 2Feb 15, 2025
- NCT06518564CollaboratorPhase 2Jan 31, 2025
- NCT06719973OfficialPhase 1Jan 6, 2025
- NCT06719973Lead sponsorPhase 1Jan 6, 2025
- NCT06509906OfficialPhase 1Oct 8, 2024
- NCT06509906Lead sponsorPhase 1Oct 8, 2024
- NCT06424717OfficialPhase 2Aug 16, 2024
- NCT06424717Lead sponsorPhase 2Aug 16, 2024
- NCT06421935Lead sponsorPhase 1Aug 7, 2024
Details
- Founded
- Darmstadt, DE Jan 1, 2006
- First NDA
- Feb 3, 2021
- Last known activity
- Nov 15, 2025
Designations held
- Orphan drug
- Priority review
- Accelerated approval